Why do statins reduce cardiovascular disease more than other lipid modulating therapies?

Eur J Clin Invest. 2014 Nov;44(11):1135-40. doi: 10.1111/eci.12342.

Authors

C Mary Schooling¹, Shiu Lun Au Yeung, Gabriel M Leung

Affiliation

¹ Li Ka Shing Faculty of Medicine, School of Public Health, The University of Hong Kong, Hong Kong, China; City University New York School of Public Health and Hunter College, New York, NY, USA.

PMID: 25252212
DOI: 10.1111/eci.12342

No abstract available

Publication types

Review

MeSH terms

Adult
Aged
Aged, 80 and over
Cardiovascular Diseases / prevention & control*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypolipidemic Agents / therapeutic use*
Male
Middle Aged
Treatment Outcome

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents